Dr Stephen Rhind

Stephen has more than 30 years of biotech industry experience, 25 of which include commercial experience representing business development (including sales) and commercial valuation of assets for a range of four public UK biotech companies, a boutique London-based consultancy and a Singaporean private company. Stephen has executed over eight major in- and out-licensing deals and concluded more than 20 major early stage R&D collaborative deals in Europe, the US and Asia with a particular expertise in small molecules and biologicals. One major deal, which totalled $550m in all milestones excluding royalties, received a peer-reviewed industry award for the most successful bio-partnership in its year in Asia.